CAS: 189261-10-7 - Immunoglobulin G4, anti-(human integrin α4) (human-mouse monoclonal AN100226 γ4-chain), disulfide with human-mouse monoclonal AN100226 light chain, dimer
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Natalizumab REF: TM-T12177CAS: 189261-10-7 | 98.00% | 163.00 €~926.00 € | Fri 10 May 24 |
 | Natalizumab REF: 3D-FN139133CAS: 189261-10-7 | Min. 95% | To inquire | Fri 14 Jun 24 |
Natalizumab
CAS:189261-10-7
Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.
Purity:
98.00%
Color and Shape:
Solid
Molecular weight:
N/A
Ref: TM-T12177
| 1mg | 163.00 € | |
| 2mg | 233.00 € | |
| 5mg | 396.00 € | |
| 10mg | 637.00 € | |
| 25mg | 926.00 € |
Estimated delivery in United States, on Friday 10 May 2024
Natalizumab
CAS:189261-10-7
Monoclonal antibody against α4-integrin
Formula:
C40H55N7O11S
Purity:
Min. 95%
Molecular weight:
841.97
Ref: 3D-FN139133
| 1mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024
